Ultrasonic Package for Buchi Mini Spray Dryer S-300
| Location: | Maryland |
|---|---|
| Posted: | Jul 8, 2026 |
| Due: | Jul 20, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | CDER-2026-133241 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Sources Sought (Original)
- Original Published Date: Jul 08, 2026 03:22 pm CDT
- Original Response Date: Jul 20, 2026 01:00 pm CDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Aug 04, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 3650 - CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
-
Place of Performance:
Silver Spring , MD 20993USA
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300. Advanced pharmaceutical manufacturing is an innovative pharmaceutical manufacturing technology, which has the potential to enhance drug quality, improve the reliability and robustness of the manufacturing process and supply chain, and increase timely access to quality medicines for the American public. One of FDA’s research priorities is to explore advanced manufacturing techniques, including manufacturing of spray dried powder for intranasal drug delivery.
CDER requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300 that can be installed on Buchi mini spray dryer S-300 and B-290. The ultrasonic nozzle should be capable of producing spray dried powders with ideal particle size for intranasal drug delivery (to produce particles up to sixty (60) microns).
- 5630 FISHERS LANE HFA-500
- ROCKVILLE , MD 20857
- USA
- David Kramer
- david.kramer@fda.hhs.gov
- Nick Sartain
- nick.sartain@fda.hhs.gov
- Jul 08, 2026 03:22 pm CDTSources Sought (Original)
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
...Follow Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance Active Contract..., ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 7/28/2026
...Follow Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... Intelligence Drug Engineering ...
DEPT OF DEFENSE
Bid Due: 10/18/2028
...Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... systems. Generative Unconstrained ...
DEPT OF DEFENSE
Bid Due: 10/18/2028
...Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... systems. Generative Unconstrained ...
DEPT OF DEFENSE
Bid Due: 10/18/2028